The European Medicines Agency (EMA) will send representatives to Russia in April as its probe of the Sputnik V COVID-19 vaccine continues.
Reuters reports Russia’s health minister Mikhail Murashko to have said on Monday, that EMA officials would arrive in the country on April 10.
Earlier this month, EMA’s human medicines committee (CHMP) started a rolling review of Sputnik V developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.
The agency said the rolling review will continue until enough evidence is available for formal marketing authorization application.
EMA said it would assess Sputnik V’s compliance with the usual EU standards for effectiveness, safety and quality.